Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina

Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

European Journal of Gastroenterology & Hepatology 2018. 30(6)

Abstract

Description

Fil: Bertot, Gustavo. Instituto Universitario de Ciencias de la Salud. Fundación Barceló; Argentina..
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has been increasing constantly and linked to the global obesity epidemic. The NAFLD histologic spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the only reliable means to diagnose and stage NASH, but its invasive nature limits its use. Therefore, the prediction of hepatic injury by means of the development of new noninvasive tests represents a growing medical need. Our aim was to evaluate matrix deposition and cell-death markers, which correlate with liver injury in an NAFLD patient cohort.

Keywords

ARTICULO, METABOLISMO, HIGADO GRASO

Citation

Endorsement

Review

Supplemented By

Referenced By

Fundación Barceló

2025 © Fundación Barceló - Todos los derechos reservados.

Desarrollado por Plasmar Web